Kawano Yayoi, Sasatsu Masanaho, Mizutani Ayako, Hirose Kaoru, Hanawa Takehisa, Onishi Hiraku
Faculty of Pharmaceutical Science, Tokyo University of Science.
Chem Pharm Bull (Tokyo). 2016 Jun 1;64(6):564-9. doi: 10.1248/cpb.c15-00926. Epub 2016 Mar 10.
Stomatitis induced by radiation therapy or cancer chemotherapy is a factor in sleep disorders and/or eating disorders, markedly decreasing patient quality of life. In recent years, disintegrating oral films that are easy to handle have been developed; therefore, we focused on the formulation of these films. We prepared an adhesive film for the oral cavity using xyloglucan (Xylo), which is a water-soluble macromolecule. We used loperamide, which has been reported to relieve pain caused by stomatitis effectively, as a model drug in this study. Films were prepared from Xylo solutions (3% (w/w)) and hypromellose (HPMC) solutions (1% (w/w)). Xylo and HPMC solutions were mixed at ratios of 1 : 1, 2 : 1, or 3 : 1 for each film, and films 2×2 cm weighing 3 g were prepared and dried at 37°C for 24 h. Physicochemical properties such as strength, adhesiveness, disintegration behavior, and dissolution of loperamide from films were evaluated. Films prepared from Xylo solution alone had sufficient strength and mucosal adhesion. On the other hand, films prepared from a mixture of Xylo and HPMC were inferior to those made from Xylo, but showed sufficient strength and mucosal adhesion and were flexible and easy to handle. The films prepared in this study are useful as adhesion films in the oral cavity.
放射治疗或癌症化疗引起的口腔炎是导致睡眠障碍和/或饮食失调的一个因素,会显著降低患者的生活质量。近年来,已开发出易于处理的口腔崩解膜;因此,我们专注于这些膜剂的配方研究。我们使用水溶性大分子木葡聚糖(Xylo)制备了一种口腔用粘附膜。在本研究中,我们使用据报道能有效缓解口腔炎引起疼痛的洛哌丁胺作为模型药物。膜剂由Xylo溶液(3%(w/w))和羟丙甲纤维素(HPMC)溶液(1%(w/w))制备而成。每种膜剂中Xylo和HPMC溶液按1∶1、2∶1或3∶1的比例混合,制备出2×2 cm、重3 g的膜剂,并在37°C下干燥24小时。对膜剂的强度、粘附性、崩解行为以及洛哌丁胺从膜剂中的溶出等理化性质进行了评估。单独由Xylo溶液制备的膜剂具有足够的强度和粘膜粘附性。另一方面,由Xylo和HPMC混合物制备的膜剂虽不如由Xylo制备的膜剂,但显示出足够的强度和粘膜粘附性,且柔韧性好、易于处理。本研究制备的膜剂可作为口腔用粘附膜使用。